剂量,剂量速率和终点之间的相互作用在FLASH放射治疗的组织节约效果中
Per Rugaard Poulsen1, Jacob Graversen Johansen1, Brita Singers Sørensen2
1Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
概括
闪光 (femtosecond辐射) 组织节约取决于辐射剂量,剂量率和研究的终点. 一张风险地图可视化了这些因素,解释了为什么严重毒性节省发生在低剂量比轻度毒性更低的剂量率.
科学领域:
- 辐射瘤学 辐射瘤学
- 放射生物学的放射生物学
- 医学物理 医学物理
背景情况:
- 闪光辐射疗法利用超高剂量率来获得潜在的治疗益处.
- 了解剂量,剂量率和生物效应之间的相互作用对于优化FLASH协议至关重要.
- 之前的体外试验数据表明,这些参数与组织毒性之间存在复杂的关系.
研究的目的:
- 在FLASH放射治疗的背景下,阐明辐射剂量,剂量率和组织毒性之间的关系.
- 开发一种可视化工具,以了解FLASH组织节约机制.
- 解释在不同剂量速率下严重毒性与轻度毒性的差异性缓解.
主要方法:
- 对现有的关于辐射毒性的体内数据的分析.
- 开发一个二维的风险区域地图,绘制剂量与剂量比率的图.
- 毒性终点与剂量-剂量率图上特定区域的相关性.
主要成果:
- 创建了一个风险区地图,在剂量-剂量-剂量率空间中划分了不同的毒性风险区域.
- 地图说明了剂量,剂量率和毒性之间的相互作用.
- 这些发现解释了为什么FLASH节省在较低剂量率的严重毒性中比轻度毒性更明显.
结论:
- FLASH组织节约是一种复杂的现象,受到剂量,剂量率和特定毒性终点的影响.
- 一个剂量-剂量率风险图为理解这些相互作用提供了一个直观的框架.
- 这个框架有助于优化FLASH放射治疗参数,以最大限度地提高治疗效益,同时最大限度地降低毒性.
相关概念视频
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
34
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
34
01:23Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
46
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates...
46
01:21Dose Size and Dosing Frequency: Determination Methods
413
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
413
01:21Dose Response Curve: Conventional Versus Nonmonotonic
72
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
72
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
34
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly...
34
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
39
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
39